Sun.Jul 28, 2024

article thumbnail

Warren Buffett starts downsizing his Bank of America bet — Here's what could lie behind the move

CNBC: Investing

Warren Buffett surprised many by reducing one of his longest held and largest positions — Bank of America. Here's what could have driven the sale.

Bank 136
article thumbnail

Vodafone says Labour must let it merge with Three UK to deliver nationwide 5G

The Guardian: Mergers & Acquisitions

Exclusive: Chief executive says government’s promise of UK-wide 5G by 2030 needs investment ‘unlocked’ by deal The chief executive of Vodafone has said Labour will fail to achieve its promise of nationwide access to 5G, which is essential for next-generation technology such as artificial intelligence, by 2030 if the telecom company’s £15bn merger with the rival Three UK is blocked.

IT 99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Wall Street analysts suggest these dividend stocks for enhanced returns

CNBC: Investing

TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Coca-Cola and Diamondback Energy

Stock 119
article thumbnail

Vital Energy to Expand Delaware Basin Position Through Bolt-on Acquisition

Global Newswire by Notified: M&A

Transaction highly accretive to key metrics; adds 68 high-return gross locations Transaction highly accretive to key metrics; adds 68 high-return gross locations

article thumbnail

15 Modern Use Cases for Enterprise Business Intelligence

Large enterprises face unique challenges in optimizing their Business Intelligence (BI) output due to the sheer scale and complexity of their operations. Unlike smaller organizations, where basic BI features and simple dashboards might suffice, enterprises must manage vast amounts of data from diverse sources. What are the top modern BI use cases for enterprise businesses to help you get a leg up on the competition?

article thumbnail

These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

CNBC: Investing

Questions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but come "too soon," one analyst said.

105
105